Latest data from September 24, 2021
Number of Health Center respondents = 16 (84% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 8,754 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 68.93% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 804 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 68.20% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 27.19% | 27.49% |
| White, Hispanic/Latino Patients | 33.84% | 34.45% |
| Black/African American, Non-Hispanic/Latino Patients | 8.14% | 7.21% |
| Black/African American, Hispanic/Latino Patients | 0.47% | 0.00% |
| Asian Patients3 | 1.82% | 1.00% |
| American Indian/Alaska Native Patients3 | 1.28% | 1.24% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.33% | 0.87% |
| Patients with More than one race3 | 1.21% | 2.24% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 13.22% | 11.94% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 4.18% | 3.73% |
| Unreported/Refused to Report Race and Ethnicity | 8.33% | 9.83% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 3,013 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 79.02% |
| COVID-19 Immunization Series Completed | 3,503 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 77.59% |
| COVID-19 Immunization Series Additional | 1,130 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 47.89% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 18.62% | 19.81% | 45.93% |
| White, Hispanic/Latino Patients | 40.42% | 39.97% | 22.30% |
| Black/African American, Non-Hispanic/Latino Patients | 9.59% | 7.96% | 6.81% |
| Black/African American, Hispanic/Latino Patients | 0.50% | 0.29% | 0.18% |
| Asian Patients3 | 1.56% | 1.80% | 3.19% |
| American Indian/Alaska Native Patients3 | 1.00% | 1.08% | 0.71% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.50% | 0.29% | 0.44% |
| Patients with More than one race3 | 0.86% | 1.00% | 0.44% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 15.70% | 16.21% | 8.14% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.79% | 1.74% | 0.53% |
| Unreported/Refused to Report Race and Ethnicity | 9.46% | 9.85% | 11.33% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 31.25% |
| 1 to 24 Hours | 37.50% |
| More Than 24 Hours | 31.25% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 18.75% |
| Staffing to administer the vaccine | 37.50% |
| Vaccine confidence | 50.00% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 0.00% |
| None | 25.00% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 88.12% |
| Average Percent of Health Center Visits Conducted Virtually | 12.19% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 37.50% |
| Number of Mobile Van Sites | 20 |
| Number of Pop-up Clinics | 17 |
| Number of School-Based Vaccination Sites | 1 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 6.25% |
| Refer patients to another organization that provides monoclonal antibody therapies | 43.75% |
| None | 50.00% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 6.25% |
| Patient awareness/education | 12.50% |
| Staffing capacity | 25.00% |
| Therapy administration/onsite logistics | 6.25% |
| Other | 12.50% |
| None | 50.00% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
